Showing results (361-370 of 450) with videos related to

Sort By:
Pageof 45
Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Clinical Rheumatology|April 21, 2018
Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort studyRosana Quintana, Mario Goñi, Nora Mathern, et al.
Lupus Science & Medicine|July 16, 2026
Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohortNuria Lozano-Rivas, Iñigo Rúa-Figueroa, Mercedes Freire-González, et al.
Arthritis Care & Research|September 28, 2019
Associations Between Classification Criteria Items in Systemic Lupus ErythematosusZahi Touma, Ricard Cervera, Ralph Brinks, et al.
Autoimmunity Reviews|August 25, 2015
Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference centerJosé Hernández-Rodríguez, Estíbaliz Ruíz-Ortiz, Adrià Tomé, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Autoimmunity Reviews|August 5, 2023
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapiesMarc Xipell, Gema M Lledó, Allyson C Egan, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Pageof 45